{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:32:47Z","timestamp":1790865167546,"version":"4.1.0"},"reference-count":26,"publisher":"The Journal of Rheumatology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Screening strategies for latent tuberculosis (TB) before starting tumor necrosis factor (TNF)-\u03b1 inhibitors have decreased the prevalence of TB among patients who are treated with these agents. However, despite vigilant screening, TB continues to be an important problem, especially in parts of the world with a high background TB prevalence. The aim of this study was to determine the factors related to TB among a large multicenter cohort of patients who were treated with anti-TNF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Fifteen rheumatology centers participated in this study. Among the 10,434 patients who were treated with anti-TNF between September 2002 and September 2012, 73 (0.69%) had developed TB. We described the demographic features and disease characteristics of these 73 patients and compared them to 7695 patients who were treated with anti-TNF, did not develop TB, and had complete data available.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Among the 73 patients diagnosed with TB (39 men, 34 women, mean age 43.6 \u00b1 13 yrs), the most frequent diagnoses were ankylosing spondylitis (n = 38) and rheumatoid arthritis (n = 25). More than half of the patients had extrapulmonary TB (39\/73, 53%). Six patients died (8.2%). In the logistic regression model, types of anti-TNF drugs [infliximab (IFX), OR 3.4, 95% CI 1.88\u20136.10, p = 0.001] and insufficient and irregular isoniazid use (&lt; 9 mos; OR 3.15, 95% CI 1.43\u20136.9, p = 0.004) were independent predictors of TB development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Our results suggest that TB is an important complication of anti-TNF therapies in Turkey. TB chemoprophylaxis less than 9 months and the use of IFX therapy were independent risk factors for TB development.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.150177","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T12:18:46Z","timestamp":1452946726000},"page":"524-529","source":"Crossref","is-referenced-by-count":43,"title":["Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-\u03b1 Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence"],"prefix":"10.3899","volume":"43","author":[{"given":"Bunyamin","family":"Kisacik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Nuri","family":"Pamuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait Burak","family":"Erer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Ozguler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Ertenli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Keser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahrettin","family":"Oksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ediz","family":"Dalkilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Pay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Balkarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli","family":"Cobankara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6zde Yildirim","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sayarlioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Cefle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayten","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Berkant","family":"Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ender","family":"Terzioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servet","family":"Akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"2018112909352525000_43.3.524.1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg263"},{"key":"2018112909352525000_43.3.524.2","doi-asserted-by":"publisher","DOI":"10.1086\/383317"},{"key":"2018112909352525000_43.3.524.3","doi-asserted-by":"publisher","DOI":"10.1086\/429994"},{"key":"2018112909352525000_43.3.524.4","unstructured":"World Health Organization . Global tuberculosis report 2015. [Internet. Accessed November 4, 2015.] Available from: www.who.int\/tb\/publications\/global_report\/en"},{"key":"2018112909352525000_43.3.524.5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.7.3394"},{"key":"2018112909352525000_43.3.524.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710093371502"},{"key":"2018112909352525000_43.3.524.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041884"},{"key":"2018112909352525000_43.3.524.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70224-6"},{"key":"2018112909352525000_43.3.524.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.23447"},{"key":"2018112909352525000_43.3.524.10","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"8","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2018112909352525000_43.3.524.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.22768"},{"key":"2018112909352525000_43.3.524.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.118935"},{"key":"2018112909352525000_43.3.524.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.24632"},{"issue":"Suppl 39","key":"2018112909352525000_43.3.524.14","first-page":"S205","article-title":"DANBIO: a nationwide registry of biological therapies in Denmark","volume":"23","author":"Hetland","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909352525000_43.3.524.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2010.11.032"},{"key":"2018112909352525000_43.3.524.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.10.001"},{"key":"2018112909352525000_43.3.524.17","unstructured":"6th International Congress on FMF and SAID 2010;L1.31. Cengiz M, Demirda\u011f F, Hatemi G, Seyahi E, Ozdogan H. The first degree relatives of FMF patients have similar mortality and morbidity rates compared to controls. [Internet. Accessed November 11, 2015.] Available from: fmf.igh.cnrs.fr\/ISSAID\/doc\/Abstracts_Amsterdam_2010.pdf"},{"issue":"Suppl 34","key":"2018112909352525000_43.3.524.18","first-page":"88","article-title":"A survey of socioeconomic status in Behcet\u2019s Syndrome","volume":"22","author":"Seyahi","year":"2004","journal-title":"Clin Exp Rheum"},{"key":"2018112909352525000_43.3.524.19","first-page":"382","article-title":"The HLA-A, -B, and -DR phenotypes and tuberculosis","volume":"132","author":"Hwang","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2018112909352525000_43.3.524.20","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(85)90051-0"},{"key":"2018112909352525000_43.3.524.21","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.046797"},{"key":"2018112909352525000_43.3.524.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01891.x"},{"key":"2018112909352525000_43.3.524.23","first-page":"542","article-title":"Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors","volume":"10","author":"Sterling","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2018112909352525000_43.3.524.24","first-page":"742","article-title":"Tuberculosis-related deaths in Queensland, Australia, 1989\u20131998: characteristics and risk factors","volume":"7","author":"Walpola","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"2018112909352525000_43.3.524.25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00408-009-9224-9","article-title":"Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis","volume":"188","author":"Silva","year":"2010","journal-title":"Lung"},{"key":"2018112909352525000_43.3.524.26","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1019"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.150177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T14:05:34Z","timestamp":1543500334000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.150177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,1]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3899\/jrheum.150177"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.150177","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,15]]}}}